| Literature DB >> 33241157 |
Leandro A Sturion1, Alexandre H Nowotny1, Fabrice Barillec2, Gilles Barette3, Gabriela K Santos1, Fellipe A Teixeira4, Karen P Fernandes1, Rubens da Silva1,5.
Abstract
BACKGROUND: A therapeutic recommendation for restoring function in individuals with chronic low back pain (CLBP) is manual therapy through manipulative spinal or muscle energy techniques.Entities:
Keywords: biomechanics; electromyography; high-velocity low-amplitude; low back pain; muscle energy; osteopathic manipulative treatment; physiotherapy; postural balance
Year: 2020 PMID: 33241157 PMCID: PMC7669951 DOI: 10.4102/sajp.v76i1.1420
Source DB: PubMed Journal: S Afr J Physiother ISSN: 0379-6175
FIGURE 1Flowchart – Consolidated Standards of Reporting Trials (CONSORT).
FIGURE 2Positioning and stabilisation during the abdominal (rectus abdominis) (a) and paravertebral (multifidus-L5 and iliocostalis-L3), (b) neuromuscular activity measuring and (c) bipodal support with load.
FIGURE 3Crossover study interventional model description.
FIGURE 4(a) High-velocity low-amplitude manipulation thrust manipulation positioning and (b) muscle energy technique positioning.
Effect of interventions (high-velocity low-amplitude thrust manipulation and muscle energy technique) on clinical variables from initial time (1 = pre-intervention); immediate (2 = post-immediate intervention on first day); and after 15 days (3 = post-final intervention).
| Variables | Groups ( | Time of intervention | Clinical differences | Groups | Times | Interaction | ||
|---|---|---|---|---|---|---|---|---|
| Initial (1) | Immediate (2) | 15 days (3) | ||||||
| NPRS (pain) | HVLA | 3.4 (2.3) | 2.5 (3.1) | 1.6 (1.8) | −1.8 | 0.816 | < 0.01 | 0.785 |
| MET | 3.8 (2.2) | 2.3 (1.8) | 1.0 (1.3) | −2.8 | - | Post hoc 1 ≠ 3 | - | |
| SF-MPQ | HVLA | 8.2 (7.9) | - | 7.2 (7.7) | −1.0 | 0.883 | 0.435 | 0.769 |
| MET | 9.1 (4.4) | - | 6.9 (4.5) | −2.2 | - | - | - | |
| RMDQ | HVLA | 7.0 (5.5) | - | 6.0 (5.0) | −1.0 | 0.714 | 0.513 | > 0.99 |
| MET | 6.4 (5.9) | - | 5.4 (3.7) | −1.0 | - | - | - | |
| FABQp | HVLA | 12.3 (8.0) | - | 10.0 (8.1) | −2.3 | 0.293 | 0.444 | 0.852 |
| MET | 14.4 (8.2) | - | 13.0 (5.2) | −1.4 | - | - | - | |
| FABQw | HVLA | 15.1 (11.2) | - | 13.0 (9.1) | −2.1 | 0.579 | 0.625 | 0.845 |
| MET | 12.8 (8.8) | - | 11.9 (8.9) | −0.9 | - | - | - | |
| Schober (cm) | HVLA | 5.4 (1.6) | - | 5.7 (1.0) | +0.3 | 0.620 | 0.708 | 0.832 |
| MET | 5.3 (1.9) | - | 5.4 (1.4) | +0.1 | - | - | - | |
FABQp, Fear-Avoidance Beliefs Questionnaire – physical activities; FABQw, Fear-Avoidance Beliefs Questionnaire – work activities; HVLA, high-velocity low-amplitude manipulation; MET, muscle energy technique; NPRS, Numeric Pain-Rating Scale; RMDQ, Roland Morris Disability Questionnaire; SF-MPQ, Short Form – McGill Pain Questionnaire.
Note: Mean values and standard deviation are given in parenthesis. Clinical difference is detectable. Negative values (NPRS, SF-MPQ, RMDQ, FABQp e FABQw) and positive values (Schober flexibility test) show clinical evolution with intervention.
Significant difference across times from intervention by post hoc analysis of ANOVA (p < 0.05).
Changes in trunk neuromuscular activation and postural control during balance bipodal in standing task without external load.
| Variables | Groups ( | Time of intervention | Clinical difference | Groups | Times | Interaction | ||
|---|---|---|---|---|---|---|---|---|
| Initial (1) | Immediate (2) | 15 days (3) | ||||||
| % MU-L5 | HVLA | 20.7 (12.9) | 23.0 (15.9) | 23.3 (14.8) | +2.6 | 0.391 | 0.932 | 0.956 |
| MET | 25.1 (12.1) | 25.7 (12.0) | 25.2 (12.9) | +0.1 | - | - | - | |
| % ILC-L3 | HVLA | 24.2 (14.7) | 25.2 (14.6) | 21.0 (11.0) | −3.2 | 0.354 | 0.463 | 0.993 |
| MET | 21.8 (8.9) | 22.3 (11.6) | 17.8 (7.4) | −4.0 | - | - | - | |
| % RABD | HVLA | 9.3 (6.2) | 10.3 (7.0) | 10.3 (5.4) | +1.0 | 0.236 | 0.899 | 0.924 |
| MET | 11.6 (4.9) | 12.2 (3.7) | 11.3 (5.1) | −0.3 | - | - | - | |
| % CO-ATIV | HVLA | 54.4 (31.2) | 50.9 (34.8) | 60.8 (36.8) | +6.4 | 0.447 | 0.838 | 0.861 |
| MET | 51.4 (19.8) | 48.3 (19.9) | 49.2 (25.9) | −2.2 | - | - | - | |
| A-COP (cm2) | HVLA | 0.6 (0.1) | 0.7 (0.1) | 0.7 (0.2) | +0.1 | 0.223 | 0.723 | 0.330 |
| MET | 0.8 (0.3) | 0.8 (0.2) | 0.6 (0.2) | −0.2 | - | - | - | |
| VEL A/P (cm/s) | HVLA | 0.7 (0.09) | 0.7 (0.08) | 0.7 (0.07) | 0.0 | 0.755 | 0.912 | 0.670 |
| MET | 0.7 (0.1) | 0.7 (0.08) | 0.7 (0.1) | 0.0 | - | - | - | |
| VEL M/L (cm/s) | HVLA | 0.5 (0.06) | 0.5 (0.08) | 0.5 (0.07) | 0.0 | 0.367 | 0.893 | 0.852 |
| MET | 0.5 (0.04) | 0.5 (0.06) | 0.5 (0.04) | 0.0 | - | - | - | |
% MU-L5, percentage of activation of multifidus muscle at the L5; % ILC-L3, percentage of activation of ilicostalis at the L3; % RABD, percentage of activation of abdominal muscle; % CO-ATIV, percentage of activation from relationship between abdominal and multifidus muscles; A-COP, centre of pressure area sway; HVLA, high-velocity low-amplitude manipulation; MET, muscle energy technique; VEL A/P e M/L, velocity sway of COP in anteroposterior and mediolateral directions.
Note: Mean values and standard deviation are given in parenthesis. Clinical difference is detectable: positive values for increase in activation and negative values for decrease in activation and balance control.
Changes in trunk neuromuscular activation and postural control during balance standing task with trunk external load.
| Variables | Groups ( | Time of intervention | Clinical difference | Groups | Times | Interaction | ||
|---|---|---|---|---|---|---|---|---|
| Initial (1) | Immediate (2) | 15 days (3) | ||||||
| % MU-L5 | HVLA | 23.4 (14.7) | 25.3 (15.1) | 25.0 (16.1) | +1.6 | 0.136 | 0.888 | 0.998 |
| MET | 28.9 (11.6) | 31.0 (14.2) | 31.1 (15.9) | +2.2 | - | - | - | |
| % ILC-L3 | HVLA | 25.5 (15.1) | 27.0 (14.8) | 22.0 (11.9) | −3.5 | 0.329 | 0.407 | 0.961 |
| MET | 23.6 (9.8) | 23.0 (10.7) | 18.7 (7.6) | −4.9 | - | - | - | |
| % RABD | HVLA | 10.6 (7.7) | 11.4 (7.2) | 10.8 (5.9) | +0.2 | 0.219 | 0.875 | 0.973 |
| MET | 12.9 (3.6) | 13.5 (5.2) | 12.3 (5.8) | −0.6 | - | - | - | |
| % CO-ATIV | HVLA | 71.4 (58.7) | 68.7 (69.4) | 67.2 (47.8) | −4.2 | 0.116 | 0.999 | 0.952 |
| MET | 47.8 (26.1) | 50.2 (24.7) | 52.7 (26.5) | +4.9 | - | - | - | |
| A-COP (cm2) | HVLA | 0.9 (0.4) | 0.9 (0.4) | 0.9 (0.4) | 0.0 | 0.202 | 0.830 | 0.614 |
| MET | 1.1 (0.4) | 1.0 (0.4) | 0.9 (0.4) | −0.2 | - | - | - | |
| VEL A/P (cm/s) | HVLA | 0.8 (0.1) | 0.8 (0.1) | 0.8 (0.1) | 0.0 | 0.655 | 0.694 | 0.499 |
| MET | 0.8 (0.1) | 0.9 (0.07) | 0.8 (0.1) | 0.0 | - | - | - | |
| VEL M/L (cm/s) | HVLA | 0.5 (0.07) | 0.5 (0.06) | 0.5 (0.07) | 0.0 | 0.546 | 0.789 | 0.951 |
| MET | 0.5 (0.07) | 0.5 (0.06) | 0.5 (0.06) | 0.0 | - | - | - | |
% MU-L5, percentage of activation of multifidus muscle at the L5; % ILC-L3, percentage of activation of ilicostalis at the L3; % RABD, percentage of activation of abdominal muscle; % CO-ATIV, percentage of activation from relationship between abdominal and multifidus muscles; A-COP, centre of pressure area sway; HVLA, high-velocity low-amplitude manipulation; MET, muscle energy technique; VEL A/P e M/L, velocity sway of COP in anteroposterior and mediolateral directions.
Note: Mean values and standard deviation are given in parenthesis. Clinical difference is detectable: positive values for increase in activation and negative values for decrease in activation and balance control.